How do you manage a patient with a history of high-risk leukemia who has increasing loss of donor chimerism in the post-transplant setting in the absence of disease relapse?  

How does graft function play into your decision making? How do you utilize post allogeneic transplant chimerism in clinical practice? Do you obtain lineage specific chimerisms? Would you offer DLI for incomplete chimerism?

Answer from: at Academic Institution